Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Market Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Overview and Market Definition
- Digital Biomarker Types
- Comparison of Traditional and Digital Biomarkers
- Pestel Analysis
- Political
- Economic
- Social
- Technological
- Environmental
- Legal
- Impact of U.S. Tariff Laws on the Digital Biomarkers Market
- Increase in Product Costs
- Effects on Supply Chain
- Opportunities for Local Production
- Conclusion
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Rising Adoption of Mhealth Apps and Wearables
- Growing Application of Digital Biomarkers in Neurodegenerative and Psychiatric Disorders
- Increasing Role of Digital Biomarkers in Clinical Trials
- Corporate Wellness Programs and Incentives
- Market Restraints
- Data Standardization and Interpretation Issues
- Difficulties in Validation of Biomarkers
- Data Privacy and Protection
- Market Opportunities
- Growing Technology Innovations
- Increasing Research Collaborations and Partnerships
Chapter 4 Regulatory Landscape
- Regulatory Scenario
- The U.S.
- Canada
- Europe
- Asia-Pacific
Chapter 5 Emerging Technologies and Developments
- Artificial Intelligence-based Digital Biomarkers
- Enhancement of Digital Biomarkers by AI and ML
- Benefits of AI-Driven Digital Biomarkers
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Market Breakdown by System Component
- Key Takeaways
- Data Collection Tools
- Data Integration Systems
- Market Breakdown by Application
- Key Takeaways
- Diagnostic Digital Biomarkers
- Monitoring Digital Biomarkers
- Predictive Digital Biomarkers
- Other Applications
- Market Breakdown by Therapeutic Area
- Key Takeaways
- Cardiovascular and Metabolic Disorders
- Psychiatric Disorders
- Neurological Disorders
- Musculoskeletal Disorders
- Respiratory Disorders
- Other Therapeutic Areas
- Market Breakdown by End-user
- Key Takeaways
- Pharmaceutical Companies and Research Institutions
- Healthcare Providers
- Patients and Caregivers
- Employers
- Payers
- Geographic Breakdown
- Market Breakdown by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Competitive Intelligence
- Key Takeaways
- Prominent Digital Biomarkers Companies
- Competitor Types and Their Strategies
- Pharmaceutical Companies
- Large Technology Companies
- Small and Medium-Size Technology Companies
- Strategic Analysis
- Agreements, Collaborations and Partnerships
- New Product Launches
- Acquisitions and Mergers
- Regulatory Approvals
Chapter 8 Sustainability in Digital Biomarkers Market: ESG Perspective
- Introduction
- Sustainability Factors
- Environmental Sustainability
- Social Sustainability
- Economic Sustainability
- Other Factors
- Scaling Sustainable Practices in Healthcare
- Business Practices Implementing Sustainable Solutions
- Conclusion
List of Tables
Summary Table: Global Market for Digital Biomarkers, by Application, Through 2030
Table 1: Digital Biomarker Types
Table 2: Traditional and Digital Biomarker Comparison
Table 3: Digital Biomarkers Examples
Table 4: Technology Innovations by Digital Biomarker Companies
Table 5: Key Research Collaborations and Partnerships, 2023-2025
Table 6: Global Market for Digital Biomarkers, by System Component, Through 2030
Table 7: Global Digital Biomarkers Market for Data Collection Tools, by Type, Through 2030
Table 8: Global Digital Biomarkers Market for Data Collection Tools, by Region, Through 2030
Table 9: Global Digital Biomarkers Market for Mobile and Web Apps, by Region, Through 2030
Table 10: Global Digital Biomarkers Market for Wearables, by Region, Through 2030
Table 11: Global Digital Biomarkers Market for Implantables and Ingestibles, by Region, Through 2030
Table 12: Global Digital Biomarkers Market for Other Data Collection Tools, by Region, Through 2030
Table 13: Global Digital Biomarkers Market for Data Integration Systems, by Region, Through 2030
Table 14: Global Market for Digital Biomarkers, by Application, Through 2030
Table 15: Global Market for Diagnostic Digital Biomarkers, by Region, Through 2030
Table 16: Global Market for Monitoring Digital Biomarkers, by Region, Through 2030
Table 17: Global Market for Predictive Digital Biomarkers, by Region, Through 2030
Table 18: Global Market Other Applications of Digital Biomarkers, by Region, Through 2030
Table 19: Global Market for Digital Biomarkers, by Therapeutic Area, Through 2030
Table 20: Global Digital Biomarkers Market for Cardiovascular and Metabolic Disorders, by Region, Through 2030
Table 21: Global Digital Biomarkers Market for Psychiatric Disorders, by Region, Through 2030
Table 22: Global Digital Biomarkers Market for Neurological Disorders, by Region, Through 2030
Table 23: Global Digital Biomarkers Market for Musculoskeletal Disorders, by Region, Through 2030
Table 24: Global Digital Biomarkers Market for Respiratory Disorders, by Region, Through 2030
Table 25: Global Digital Biomarkers Market for Other Therapeutic Areas, by Region, Through 2030
Table 26: Global Market for Digital Biomarkers, by End User, Through 2030
Table 27: Global Digital Biomarkers Market for Pharmaceutical Companies and Research Institutions, by Region, Through 2030
Table 28: Global Digital Biomarkers Market for Healthcare Providers, by Region, Through 2030
Table 29: Global Digital Biomarkers Market for Patients and Caregivers, by Region, Through 2030
Table 30: Global Digital Biomarkers Market for Employers, by Region, Through 2030
Table 31: Global Digital Biomarkers Market for Payers, by Region, Through 2030
Table 32: Global Market for Digital Biomarkers, by Region, Through 2030
Table 33: North American Market for Digital Biomarkers, by System Component, Through 2030
Table 34: North American Market for Data Collection Tools, by Type, Through 2030
Table 35: North American Market for Digital Biomarkers, by Application, Through 2030
Table 36: North American Market for Digital Biomarkers, by Therapeutic Area, Through 2030
Table 37: North American Market for Digital Biomarkers, by End User, Through 2030
Table 38: North American Market for Digital Biomarkers, by Country, Through 2030
Table 39: European Market for Digital Biomarkers, by System Component, Through 2030
Table 40: European Market for Data Collection Tools, by Type, Through 2030
Table 41: European Market for Digital Biomarkers, by Application, Through 2030
Table 42: European Market for Digital Biomarkers, by Therapeutic Area, Through 2030
Table 43: European Market for Digital Biomarkers, by End User, Through 2030
Table 44: European Market for Digital Biomarkers, by Country, Through 2030
Table 45: Asia-Pacific Market for Digital Biomarkers, by System Component, Through 2030
Table 46: Asia-Pacific Market for Data Collection Tools, by Type, Through 2030
Table 47: Asia-Pacific Market for Digital Biomarkers, by Application, Through 2030
Table 48: Asia-Pacific Market for Digital Biomarkers, by Therapeutic Area, Through 2030
Table 49: Asia-Pacific Market for Digital Biomarkers, by End User, Through 2030
Table 50: Asia-Pacific Market for Digital Biomarkers, by Country, Through 2030
Table 51: RoW Market for Digital Biomarkers, by System Component, Through 2030
Table 52: RoW Market for Data Collection Tools, by Type, Through 2030
Table 53: RoW Market for Digital Biomarkers, by Application, Through 2030
Table 54: RoW Market for Digital Biomarkers, by Therapeutic Area, Through 2030
Table 55: RoW Market for Digital Biomarkers, by End User, Through 2030
Table 56: RoW Market for Digital Biomarkers, by Sub-Region, Through 2030
Table 57: Prominent Digital Biomarkers Companies
Table 58: Agreements, Collaborations and Partnerships in the Digital Biomarkers Market, 2023-2025
Table 59: New Product Launches in the Digital Biomarkers Market, 2022-2025
Table 60: Acquisitions and Mergers in the Digital Biomarkers Market, 2024 and 2025
Table 61: Regulatory Approvals in the Digital Biomarkers Market, 2022-2025
Table 62: Information Sources for this Report
Table 63: Abbreviations Used in this Report
Table 64: ActiGraph LLC.: Company Snapshot
Table 65: ActiGraph LLC.: Product Portfolio
Table 66: ActiGraph LLC.: News/Key Developments, 2023-2025
Table 67: Akili Inc.: Company Snapshot
Table 68: Akili Inc.: Product Portfolio
Table 69: Akili Inc.: News/Key Developments, 2024
Table 70: Alivecor Inc.: Company Snapshot
Table 71: AliveCor Inc.: Product Portfolio
Table 72: AliveCor Inc.: News/Key Developments, 2024 and 2025
Table 73: Altoida: Company Snapshot
Table 74: Altoida: Product Portfolio
Table 75: Embic Corp.: Company Snapshot
Table 76: Embic Corp.: Product Portfolio
Table 77: Empatica Inc.: Company Snapshot
Table 78: Empatica Inc.: Product Portfolio
Table 79: Empatica Inc.: News/Key Developments, 2023 and 2024
Table 80: Evidation Health Inc.: Company Snapshot
Table 81: Evidation Health Inc.: Product Portfolio
Table 82: Evidation Health Inc.: News/Key Developments, 2022-2024
Table 83: Feel Therapeutics: Company Snapshot
Table 84: Feel Therapeutics: Product Portfolio
Table 85: Feel Therapeutics: News/Key Developments, 2022 and 2023
Table 86: Huma: Company Snapshot
Table 87: Huma: Product Portfolio
Table 88: Huma: News/Key Developments, 2023-2025
Table 89: IXICO plc: Company Snapshot
Table 90: IXICO plc: Financial Performance, FY 2023 and 2024
Table 91: IXICO plc: Product Portfolio
Table 92: IXICO plc: News/Key Developments, 2024 and 2025
Table 93: Kinsa Inc.: Company Snapshot
Table 94: Kinsa Inc.: Product Portfolio
Table 95: Kinsa Inc.: News/Key Developments, 2024
Table 96: Koneksa Health: Company Snapshot
Table 97: Koneksa Health: Product Portfolio
Table 98: Koneksa Health: News/Key Developments, 2023 and 2024
Table 99: Neurotrack Technologies Inc.: Company Snapshot
Table 100: Neurotrack Technologies Inc.: Product Portfolio
Table 101: Neurotrack Technologies Inc.: News/Key Developments, 2022
Table 102: VivoSensMedical GmbH: Company Snapshot
Table 103: VivoSensMedical GmbH: Product Portfolio
Table 104: VivoSensMedical GmbH: News/Key Developments, 2021
Table 105: Winterlight Labs: Company Snapshot
Table 106: Winterlight Labs: Product Portfolio
List of Figures
Summary Figure: Global Market Share of Digital Biomarkers, by Application, 2024
Figure 1: PESTEL Analysis: Digital Biomarkers Market
Figure 2: Digital Biomarkers Market Dynamics
Figure 3: Distribution of Clinical Trials with Digital Biomarkers as Endpoints, by Therapeutic Area
Figure 4: Global Market Shares of Digital Biomarkers, by System Component, 2024
Figure 5: Global Digital Biomarkers Market Share of Data Collection Tools, by Type, 2024
Figure 6: Global Digital Biomarkers Market Share of Mobile and Web Apps, by Region, 2024
Figure 7: Global Digital Biomarkers Market Share of Wearables, by Region, 2024
Figure 8: Global Digital Biomarkers Market Share of Implantables and Ingestibles, by Region, 2024
Figure 9: Global Digital Biomarkers Market Share of Other Data Collection Tools, by Region, 2024
Figure 10: Global Digital Biomarkers Market Share of Data Integration Systems, by Region, 2024
Figure 11: Global Market Share of Digital Biomarkers, by Application, 2024
Figure 12: Global Market Share of Diagnostic Digital Biomarkers, by Region, 2024
Figure 13: Global Market Share of Monitoring Digital Biomarkers, by Region, 2024
Figure 14: Global Market Share of Predictive Digital Biomarkers, by Region, 2024
Figure 15: Global Market Share of Other Applications of Digital Biomarkers, by Region, 2024
Figure 16: Global Market Share of Digital Biomarkers, by Therapeutic Area, 2024
Figure 17: Global Digital Biomarkers Market Share of Cardiovascular and Metabolic Disorders, by Region, 2024
Figure 18: Global Digital Biomarkers Market Share of Psychiatric Disorders, by Region, 2024
Figure 19: Global Digital Biomarkers Market Share of Neurological Disorders, by Region, 2024
Figure 20: Global Digital Biomarkers Market Share of Musculoskeletal Disorders, by Region, 2024
Figure 21: Global Digital Biomarkers Market Share of Respiratory Disorders, by Region, 2024
Figure 22: Global Digital Biomarkers Market Share of Other Therapeutic Areas, by Region, 2024
Figure 23: Global Market Share of Digital Biomarkers, by End User, 2024
Figure 24: Global Digital Biomarkers Market Share of Pharmaceutical Companies and Research Institutions, by Region, 2024
Figure 25: Global Digital Biomarkers Market Share of Healthcare Providers, by Region, 2024
Figure 26: Global Digital Biomarkers Market Share of Patients and Caregivers, by Region, 2024
Figure 27: Global Digital Biomarkers Market Share of Employers, by Region, 2024
Figure 28: Global Digital Biomarkers Market Share of Payers, by Region, 2024
Figure 29: Global Market Share of Digital Biomarkers, by Region, 2024
Figure 30: North American Market Share of Digital Biomarkers, by Country, 2024
Figure 31: U.S. Elderly* Population, 2010-2050
Figure 32: European Market Share of Digital Biomarkers, by Country, 2024
Figure 33: Asia-Pacific Market Share of Digital Biomarkers, by Country, 2024
Figure 34: RoW Market Share of Digital Biomarkers, by Sub-Region, 2024
Figure 35: Digital Biomarkers: Competitor Types and Their Strategies
Figure 36: Sustainability Factors in the Digital Biomarkers Industry
Figure 37: Scaling Sustainable Practices in Healthcare
Figure 38: IXICO plc: Revenue Share, by Country/Region, FY 2024
